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Abstract: As the retinal pigment epithelium (RPE) ages, a number of structural changes occur, 
including loss of melanin granules, increase in the density of residual bodies, accumulation of 
lipofuscin, accumulation of basal deposits on or within Bruch’s membrane, formation of drusen 
(between the basal lamina of the RPE and the inner collagenous layer of Bruch’s membrane), 
thickening of Bruch’s membrane, microvilli atrophy and disorganization of the basal infoldings. 
Although these changes are well known, the basic mechanisms involved in them are frequently 
poorly understood. These age-related changes progress slowly and vary in severity in different 
individuals. These changes are also found in age-related macular degeneration (AMD), a late 
onset disease that severely impacts the RPE, but they are much more pronounced than during 
normal aging. However, the changes in AMD lead to severe loss of vision. Given the many sup-
porting functions which the RPE serves for the retina, it is important to decipher the age-related 
changes in this epithelium in order to understand age-related changes in vision.
Keywords: retinal pigment epithelium, aging, age-related macular degeneration (AMD), ocular 
disorders, retinal disease
Age-related changes in the RPE
The retinal pigment epithelium (RPE) performs highly specialized metabolic and 
transport functions essential for homeostasis of the neural retina (Bok 1993). These 
include phagocytosis of photoreceptor-shed outer segments, transport of nutrients 
into and removal of waste products from photoreceptor cells and retinoid transport 
and regeneration. The RPE is a low cuboidal epithelium containing very long thin and 
sheet-like microvilli on its apical surface that project into the interphotoreceptor matrix 
where they interact with the tips of the rod and cone photoreceptor outer segments (Bok 
1993). The apical surface of RPE cells supports and carries out the diurnal phagocytic 
removal of spent photoreceptor tips. One RPE cell supports 30–50 photoreceptors, 
which shed daily ~5% of their outer segment mass (Zinn and Benjamin-Henkind 1979). 
The basal surface of RPE cells displays highly convoluted basal infoldings that attach 
to a specialized Bruch’s basement membrane, an acellular layer separating the RPE 
from the choriocapillaris. The RPE’s basal surface participates in extensive metabolic 
exchanges with the blood vessels in the underlying choriocapillaris.
An accumulation of discrete but pronounced structural changes occurs in aging 
eyes. In the aged retina, an overall thinning is apparent, due to loss of neurons from 
all the neuronal cells and also shortening of photoreceptor cells. The RPE speciﬁ  cally 
is known to undergo several structural changes, including loss of melanin granules, 
increase in the number of residual bodies, accumulation of the age pigment lipofuscin, 
accumulation of basal deposits on or within Bruch’s membrane (BM), formation of 
drusen (between the basal lamina of the RPE and the inner collagenous layer of BM), 
thickening of BM, RPE microvilli atrophy and disorganization of basal infoldings 
(Boulton and Dayhaw-Barker 2001). Some of these changes are shown in Figure 1 Clinical Ophthalmology 2008:2(2) 414
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(B, D, F, H, J) and they will be discussed in detail in the 
following text. The RPE aging changes progress slowly and 
are of varying severity in different eyes.
The RPE contains two kinds of pigment, namely lipo-
fuscin and melanin. Melanin is an insoluble high molecular 
weight polymer derived from the enzymatic oxidation of 
tyrosine and dihydroxyphenylalanine, linked to proteins 
and contained in membrane-limited granules in the RPE 
melanosomes. Recently a comprehensive determination 
of the protein composition of melanosomes isolated from 
human melanoma cells was reported using proteomics (Chi 
et al 2006). The identiﬁ  ed proteins included 16 homologs to 
mouse coat color genes, many associated with human pig-
mentary diseases, pigment epithelium-derived factor (PEDF) 
and SLC24A5 (sodium/potassium/calcium exchanger 5, 
NCKX5). However, these melanosomes may be different 
Figure 1 Age-related changes in human RPE. Observation of the structural differences in RPE from young (23 year-old, A, C, E, G, I) and aged (75 and 88 year-old, B, D, F, 
H, J) human donors. Aged RPE from human donors displays loss of melanin granules (MP, arrowheads in A, E) and accumulation of the age pigment lipofuscin (Lip) (B, D), as 
observed by the presence of increased autoﬂ  uorescent granules when observed on epiﬂ  uorescence in the green channel (FITC ﬁ  lter: excitation 495 nm/emission 519 nm) in 
aged RPE (D) when compared to young RPE (C). Additional observation of the aged RPE displayed formation of drusen (D) (between the basal lamina of the RPE and the inner 
collagenous layer of Bruch’s membrane) (F), thickening of Bruch’s membrane and basal infoldings disorganization (J) when processed and analyzed by electron microscopy. In 
addition, in the aged RPE cells melanin granules are frequently seen in association with lipofuscin (melanolipofuscin, MLF) granules (H). Young RPE displays melanin pigments on 
their apical surface (A, E, G) while aged RPE contains mostly lipofuscin granules (B, H). Differential interference contrast microscopy images (A, B). Semi-thin epon sections 
stained with toluidine blue of young (E) and aged RPE (F) examined in bright ﬁ  eld.
Abbreviations: BI, basal infoldings; RPEBM, RPE basement membrane; ICL, inner collagenous layer; MEL, middle elastic layer; OCL, outer collagenous layer; EBM, choroidal 
endothelial cell basement membrane; Bars: (A to D), 10 μm; (E, F), 200 μm; (G, H), 2 μm; (I, J), 1 μm.Clinical Ophthalmology 2008:2(2) 415
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from the ones present in the RPE. RPE melanin originates 
from neural ectoderm, whereas the one in melanocytes 
originates from neural crest (Feeney 1978). In aged RPE 
cells melanin granules are frequently seen in association with 
lysosomes (melanolysosomes, MLL) and lipofuscin granules 
(melanolipofuscin, MLF; Figure 1H), which suggests that 
any protein bound to melanin may be degraded. In addition, 
melanosomes may undergo photobleaching with aging, 
which can diminish the antioxidant efﬁ  ciency of melanin 
(Sarna et al 2003). Altogether, these observations suggest that 
changes in melanin granules possibly contribute to some of 
the senile changes evident in the RPE. A recent manuscript 
observed the accumulation of MLF in human RPE from 
different decades of life and assessed their phototoxicity to 
RPE cultures in vitro. The analysis of the composition of 
MLF granules suggested that, in contrast to lipofuscin, they 
do not contain photoreceptor-speciﬁ  c proteins. The authors 
suggest that MLF may not originate from photoreceptor 
outer segments phagocytosis but that MLF accumulates as 
a result of the melanosomal autophagocytosis of RPE cells 
(Warburton et al 2006).
Accumulation of secondary lysosomes and residual 
bodies containing lipofuscin, known as dense bodies, has 
been observed in post-mitotic and intermitotic cells during 
aging (Schmucker and Sachs 2002; Morales et al 2004; 
Kubasik-Juraniec et al 2004). The general consensus is 
that the accumulation of these dense bodies represents 
lysosomal aging and is a universal index of cellular senes-
cence (Schmucker and Sachs 2002; Terman et al 2007). It 
has been well established that the RPE has an extremely 
active lysosomal system capable of degrading thousands of 
phagocytosed outer segment disks per day (Young 1971; Zinn 
and Benjamin-Henkind 1979). The aged RPE accumulates 
indigested residues of this phagocytic process as residual 
bodies (Feeney-Burns et al 1987).
Lipofuscin pigment has been described as intracellular 
yellow-brown autoﬂ  uorescent granules exhibiting sudano-
philic, osmiophilic, argyrophilic and periodic acid-Schiff-
positive and acid-fast staining characteristics (Feeney 1978). 
Lipofuscin is a heterogeneous material composed of a mix-
ture of lipids and different ﬂ  uorescent compounds, the main 
ﬂ  uorophore of which has been identiﬁ  ed as the pyridinium 
bis-retinoid, N -retinylidene-N -retinylethanolamine (A2E), 
a derivative of vitamin A. RPE lipofuscin is unique because 
it originates mainly from the phagocytosed photoreceptor 
outer segments as was demonstrated in early studies. For 
instance, analysis of the chemical composition of RPE cells 
revealed that it is different from the photoreceptor outer 
segments (Berman et al 1974). In addition, investigations 
undertaken on the Royal College of Surgeons (RCS) rats 
showed that in this strain, which fails to phagocytose shed 
outer segments, lipofuscin is signiﬁ  cantly diminished (Katz 
et al 1986; Eldred and Lasky 1993). Moreover, the accumula-
tion of autoﬂ  uorescent debris was observed in a transgenic 
mouse line expressing a mutated form of cathepsin D that 
is enzymatically inactive, thereby impairing the processing 
of phagocytosed photoreceptor outer segments by the RPE 
cells (Rakoczy et al 2002). A recent study established the 
presence of extragranular material present in preparations 
of lipofuscin routinely isolated by sucrose density gradient 
centrifugation. In this study, the lipofuscin granules were 
isolated and further puriﬁ  ed by digestion of the extragranular 
material with proteinase K or by wash with SDS detergent. 
Raw and puriﬁ  ed granules were tested for their protein 
content. The results demonstrated that: debris-free granules 
contain little or no protein; the protein associated with lipo-
fuscin granules is essentially all extra-granular and appears to 
be signiﬁ  cantly modiﬁ  ed by posttranslational modiﬁ  cations 
(Renganathan et al 2007). Lipofuscin granules ﬁ  rst appear 
in the basal portions of RPE cells of young eyes (1st decade, 
Figure 1C), whereas in older eyes (9th decade, Figure 1D), 
lipofuscin granules form into clumps and ﬁ  ll the entire RPE 
cell cytoplasm (Wing et al 1978). It is suggested that the 
accumulation of lipofuscin in aged RPE is connected to RPE 
functional degeneration either by “clogging” of the cytoplasm 
or by increased oxidative stress in the cell. Support for the 
ﬁ  rst mechanism (clogging of the cytoplasm) comes from a 
recent study, which implanted glycoxidized microspheres 
(Glycox-MS) as imitation for lipofuscin into the subretinal 
space of 10–12 week-old rabbits. Observations were carried 
out from 1 to 16 weeks after subretinal implantation. Glycox-
MS stagnated for a prolonged period in the cytoplasm of RPE 
cells and eyes implanted with glycox-MS produced drusen-
like deposits at a signiﬁ  cantly higher frequency (Yasukawa 
et al 2007). Support for the second mechanism (increased 
oxidative stress in the RPE cells) comes from observations 
that lipofuscin is a photoinducible generator of superoxide 
anion, singlet oxygen and hydrogen peroxide (Boulton et al 
1993; Gaillard et al 1995; Rozanowska et al 1995, 1998). 
Thus, visible-light irradiation (400–1100 nm) of lipofuscin 
granules results in extra-granular oxidation of lipids and inac-
tivation of lysosomal and antioxidant enzymes (Wassel et al 
1999). In addition, it was shown that A2E has phototoxic and 
detergent properties and is capable of inducing disintegration 
of membrane-bound organelles in RPE cultures. Finally, 
lipofuscin can also interfere with the antioxidant properties of Clinical Ophthalmology 2008:2(2) 416
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melanin (Boulton et al 1993; Rozanowska et al 1995; Schutt 
et al 2001, 2002; Wang et al 2006). The aged RPE displays 
increased intracellular accumulation of the blue-shifted auto-
ﬂ  uorescence lipofuscin granules, which coincides with the 
depletion of melanin pigments (Feeney-Burns 1984; Han et al 
2007). RPE lipofuscin granules exhibit a broad band emission 
spectrum with a peak at 600 nm and subsidiary shoulders 
located at 470 and 550 nm when excited at 364 nm; a 680 
peak appears with increasing age (Boulton et al 1990).
Bruch’s membrane (BM) is a pentalaminar structure 
composed of the RPE basement membrane, inner collag-
enous layer, middle elastic layer, outer collagenous layer, and 
the choroidal endothelial cell basement membrane (Hogan 
and Alvarado 1967). This acellular extracellular meshwork 
found between the RPE and the choroid, which is 2–4 μm 
thick is known to undergo increased thickening (Figure 1J), 
chemical reconﬁ  guration of both proteins and lipids, and 
debris accumulation during aging (Pauleikhoff et al 1990; 
Okubo et al 1999; Zarbin 2004). The aged BM displays an 
exponential increase in phospholipids, triglycerides, fatty 
acids, and free cholesterol content (Sheraidah et al 1993). 
Protein reconﬁ  guration in the form of post-translational 
modiﬁ  cations has been reported in the BM. Immunore-
activity to some of the advanced glycation end product 
(AGE) adducts increases in the aged BM (Farboud et al 
1999; Handa et al 1999). Although the precise contribution 
of AGEs to the retinal pathology remains to be elucidated, 
AGEs are recognized as important initiators of age-related 
dysfunction, inasmuch as they are known to cause protein 
cross-linking, reduced solubility, enzymatic dysfunction, and 
loss of receptor recognition (Baynes 2001). A recent study 
combined both Raman microscopy and speciﬁ  c chemical 
quantiﬁ  cation to assess deﬁ  ned AGE adducts and quantify 
AGE-related spectral alterations in aged BM of postmortem 
eyes (Glenn et al 2007). The analysis showed that the AGEs 
pentosidine, carboxymethyllysine (CML), and carboxyethyl-
lysine (CEL) occurred at signiﬁ  cantly higher levels in BM-
Ch with age (Glenn et al 2007). In addition, several recent 
studies demonstrated that tissue metalloproteinase inhibitor 
3 (TIMP-3), vitronectin, annexins, crystallins, clathrin and 
adaptin proteins were crosslinked as evidenced from western 
blots that showed the presence of these proteins at several 
regions of the gel (Nakata et al 2005; Rayborn et al 2006; 
Bando et al 2007).
In addition, BM is under constant cycles of pressure-
induced stress as a result of the choroidal ﬂ  ow oscillating 
with the cardiac rhythm. The mechanical properties of BM 
are critical determinants of its physiology. Speciﬁ  cally, the 
elastic properties of BM will determine its ability to sustain 
potentially damaging stress and strain perturbations. Recently 
the mechanical properties of isolated human BM were inves-
tigated and related to aging. This study demonstrated that 
the elasticity of human BM-Ch complex decreased linearly 
with aging after the age of 21 with an approximate reduc-
tion of 1% per year. On the other hand, the recoil capacity 
of Bruch’s membrane-choroid was not affected by aging 
(Ugarte et al 2006).
Drusen are debris-like deposits that accumulate below 
the RPE along BM (Figure 1F). Clinically, they are char-
acterized by the terms “hard” and “soft” according to their 
size and their appearance in ﬂ  uorescein angiography. Hard 
drusen are small, hard, round and have well deﬁ  ned borders 
(Marshall et al 1998). Hard drusen occur in 80% of postmor-
tem eyes, and are usually small, they are hyperﬂ  uorescent on 
ﬂ  uorescein angiography, a characteristic that may be related 
to the fact that they are enriched in phospholipids (Bird and 
Marshall 1986; Pauleikhoff et al 1992; Arnold et al 1997). 
On the other hand, soft drusen are extensive, diffuse, large 
deposits, which have borders not sharply deﬁ  ned, and rarely 
occur before the age of 55 (Garner et al 1994; Marshall et al 
1998). Soft drusen are hypoﬂ  uorescent in ﬂ  uorescein angiog-
raphy and display a high content of neutral fats (Pauleikhoff 
et al 1992; Arnold et al 1997), vesicles, membranous debris, 
and wide-spaced collagen. Generally, hard drusen do not lead 
to loss of vision, but soft drusen are considered contribu-
tors to the pathology of age-related macular degeneration 
(AMD). Soft drusen deposition in the macula precedes 
visual loss; it deﬁ  nes the early stages of AMD together with 
pigmentary changes of the RPE. Deposition of soft drusen 
in the macula is considered the precursor lesion that leads 
to the development of geographic atrophy (dry AMD) and 
choroidal neovascularization (wet AMD), which are the late 
forms of AMD. The different types of AMD will be discussed 
in detail in the following text.
A recent proteomic study carried out on isolated drusen 
from both AMD and normal donors found up to 65% of the 
proteins identiﬁ  ed common to both donor types. TIMP-3, 
clusterin, vitronectin, and serum albumin were the most 
common proteins observed in normal donor drusen, whereas 
crystallin was detected more frequently in AMD donor 
drusen. In addition, protein from both normal and AMD 
donors such as vitronectin, TIMP-3, clusterin, complement 
C9, lysosyme C, serum amyloid P, and apolipoprotein E 
migrated in multiple mass ranges from the top to the bottom 
of the gel, suggesting the presence of covalent crosslinks 
(Crabb et al 2002).Clinical Ophthalmology 2008:2(2) 417
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Recent work from several groups also suggests that local 
inﬂ  ammation plays a role in drusen formation in a process 
analogous to that which occurs in other age-related diseases 
such as Alzheimer’s disease and atherosclerosis, in which 
there is an accumulation of extracellular plaques and deposits 
causing a local chronic inﬂ  ammatory response which in turn 
exacerbates the effects of the primary stimuli (Hageman 
et al 2001; Johnson et al 2001; Anderson et al 2002). This 
hypothesis is supported by evidence revealing the localiza-
tion of several proteins involved in the immune system such 
as immunoglobulins; components of complement cascade 
(such as C5b-9 complex, complement factor F); MHC class 
II antigens; cell-associated molecules, including HLA-DR 
and speciﬁ  c CD antigens (Mullins et al 2000; Hageman et al 
2001; Johnson et al 2001; Anderson et al 2002).
Few studies have demonstrated age-related effects on 
RPE microvilli. A ﬁ  nding common to all of them was the 
shortening of the RPE microvilli (Katz and Robison 1984; 
Lai and Rana 1986; Weisse 1995). Previously, we have been 
able to isolate intact RPE microvilli from mice (Bonilha 
et al 2004) and characterize its content using proteomics. 
Several of the identiﬁ  ed proteins in the microvilli fraction 
are antioxidant enzymes and have been shown to undergo 
speciﬁ  c modulation during aging. These include lactate 
dehydrogenase, glutathione S-transferase, peroxiredoxin, 
ceruloplasmin, and superoxide dismutase. Our data are sup-
ported by several reports, which identiﬁ  ed the presence of 
antioxidative enzymes in the microvilli of kidney (Davies 
et al 1993; Muse et al 1994), respiratory tract epithelium 
(Coursin et al 1992), and intestine (Davis et al 1989), among 
others. Oxidation is a very important mechanism in aging 
(Kohen and Nyska 2002; Balazy and Nigam 2003; Van Rem-
men et al 2003; Kregel and Zhang 2007). RPE apical micro-
villi shortening is also expected to affect several of the key 
functions carried out by the apical surface. Examples of these 
include phagocytosis of shed photoreceptor outer segments 
through the receptors αvβ5 vitronectin receptor and the Mer 
tyrosine kinase (MerTK) receptor protein; apical transport 
involving transporters such as Na,K-ATPase, the glucose 
transporter (Glut-1), monocarboxylate transporter 1 (MCT1), 
basigin, the Kir7.1 K+ channel, chloride intracellular channel 
6, carbonic anhydrase XIV, among others; and visual cycle 
function through the involvement of CRALBP, RPE65, 
IRBP, and CRBP (Rayborn et al 2005). These changes could 
alter the retinal metabolic equilibrium and accelerate degen-
erative processes in the aging retina. Our ongoing research 
aims to identify a protein proﬁ  le that is uniquely present in 
aged RPE cells. Our ﬁ  ndings will lead to future studies on 
the functional consequence of these proteins and to a more 
complete understanding of the pathogenesis of AMD.
Animal models in RPE aging studies
A good animal model should reduplicate biochemical, mor-
phological, and molecular changes shown in humans during 
aging. Much of our understanding of the biological changes 
that occur with aging has come from studies using rodents. 
Similarities in the physiology and cell biology of aging in 
humans and rodents make rodents a valuable model with 
which to test therapeutic interventions for aging, and they are 
small enough to allow for the use of statistically robust sample 
sizes. There are several rodent models to choose from. The 
National Institute on Aging (NIA) supports many resources 
to facilitate the use of animal models for biogerontological 
research, including aged rodent colonies, the aged rodent 
tissue bank, and tissue arrays from aged rodents (Nadon 
2006). One of the rodent models available for aging studies 
is the rat F1 F344/BN hybrid. The aged (24–25 month-old) 
F344/BN rat displays several of the RPE age-related changes 
described above; speciﬁ  cally, BM thickening, lipofuscin 
accumulation, accumulation of residual bodies, decrease in 
RPE density and microvilli atrophy when compared to young 
(3–4 month-old) rats (Figure 2).
Age-related changes in RPE density
Numerous studies have been undertaken to determine 
changes in RPE density with age. However, previous studies 
yielded contradictory results: Some found that RPE density 
increased with age (Tso and Friedman 1968; Harman et al 
1997; Leung et al 2004). Others found that it decreased 
(Streeten 1969; Gao and Hollyﬁ  eld 1992; Watzke et al 1993); 
while yet another study found that it did not change with age 
at all (Dorey et al 1989). The discrepancies among these 
studies can be explained by the number of eyes analyzed and 
by the nature of the analyses which were carried out. Use of 
cross-sections allows analysis of a restricted number of cells, 
whereas whole-mount preparations allows analysis of the 
whole population of cells in the tissue. One study (Gao and 
Hollyﬁ  eld 1992) investigated this issue analyzing eyes from 
donors from the 2nd to the 9th decade. Tissue fragments were 
obtained and analyzed as whole-mounts from the fovea and 
the retinal equator. Observations suggested that foveal RPE 
is denser, with cells smaller and more homogeneous, inde-
pendent of the age of the donor, as shown in Figure 3A and 
C. Linear regression of the obtained data yielded a signiﬁ  cant 
negative slope of RPE density in the retinal equator, sug-
gesting a uniform rate of equatorial RPE loss during aging. Clinical Ophthalmology 2008:2(2) 418
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Figure 2 Age-related changes in F1 F344BN hybrid rat RPE. Observation of young (3–4 month-old, A) and aged (24–25 month-old, B) F1 F344BN hybrid rats reveals several 
of the RPE age-related changes previously described. These include: Bruch’s membrane thickening (D), accumulation of residual bodies, and microvilli atrophy (B). In addition, 
bright-ﬁ  eld analysis of aged RPE whole-mounts reveals decrease in RPE density (G) while epiﬂ  uorescence in the green channel (FITC ﬁ  lter: excitation 495 nm/emission 519 nm) 
reveals increased lipofuscin accumulation (H) when compared to the young RPE cells (E and F). A–D. Transmission electron microscopy.
Abbreviations: BI, basal infoldings; MV, microvilli; POS, photorecptor outer segments; RPEBM, RPE basement membrane; ICL, inner collagenous layer; MEL, middle elastic layer; 
OCL, outer collagenous layer; EBM, choroidal endothelial cell basement membrane; Bars: (A and B), 1 μm; (C and D), 2 μm; and (C to F), 200 μm.Clinical Ophthalmology 2008:2(2) 419
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On the other hand, foveal RPE density was relatively stable 
from the 2nd through the 9th decades, with no signiﬁ  cant 
decrease in cell density (Gao and Hollyﬁ  eld 1992).
Another study investigated the age-related changes in 
RPE in an even larger number of eyes from donors from 
the 2nd to the 9th decade (Panda-Jones et al 1996). Using a 
3 mm trephine the authors collected RPE/retina/choroid in 
the fovea and in the superior, inferior, temporal, and nasal 
meridians in 6 rings that were arranged concentrically around 
the fovea. These samples were also analyzed as whole-mount 
preparations. As in the previous study, the authors concluded 
that RPE density at the foveal center was the highest and that 
it decreased signiﬁ  cantly from the fovea to the mid-retinal 
periphery. In the periphery, RPE density was the highest in 
the nasal region. The age-related loss was most marked in 
the fovea and the mid periphery. The authors determined 
that RPE cell density in the fovea decreased signiﬁ  cantly by 
about 0.3% per year with increasing age.
The elderly suffer from loss of visual acuity (Weale 
1975; Del Viva and Agostini 2007), color perception (Ohta 
and Kato 1975; Page and Crognale 2005), and dark-adap-
tation sensitivity (McFarland et al 1960; Werner 2005). 
These conditions are probably associated with age-related 
death of RPE and photoreceptors. It is important to under-
stand the mechanisms involved in these cell deaths. One 
study speciﬁ  cally addressed this issue by analyzing age-
related RPE apoptosis through terminal deoxynucleotidyl 
transferase-mediated dUTP nick end (TUNEL)-labeling in 
whole-mount preparations of eyes divided into 4 concentric 
regions centered on the fovea. Overall, analysis showed that 
TUNEL-positive RPE cells were uncommon. There was a 
signiﬁ  cant positive correlation between the donor’s age and 
the number of apoptotic cells. Analysis of the individual 
regions revealed that within zone 1 (0–1.5 mm radius) the 
proportion of apoptotic RPE cells started to increase in the 
6th decade. There was also an age-dependent increase in 
Figure 3 Age-related changes in RPE density. Bright-ﬁ  eld micrographs of RPE whole- mounts from both young (A and B) and aged (C and D) donor eyes. Observations were 
carried out both in the fovea (A and C) and periphery (B and D) of the eyes. Foveal RPE cells are smaller and more homogeneous than the peripheral RPE cells independent 
of the age of the donor. Bas, 200 μm.Clinical Ophthalmology 2008:2(2) 420
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apoptosis within zone 2 (1.5–3.0 mm radius, at a much lower 
number) (Del Priore et al 2002).
RPE changes and loss in AMD
AMD is the most common cause of irreversible blindness in 
the elderly population in industrialized countries (Leibowitz 
et al 1980; Klein et al 1995; Kelin et al 2004). Although aging 
is an important event that contributes to the pathogenesis of 
AMD, it does not directly lead to the occurrence of AMD 
(Sarks 1976; Young 1987). AMD occurs in two forms: neo-
vascular or exudative (wet) and atrophic (dry) AMD. Neovas-
cular AMD is characterized by abnormal growth of capillaries 
from the choroid into the Bruch’s membrane and RPE and 
by subsequent exudation of ﬂ  uid, lipid, and blood. It results 
ultimately in a disciform scar in the macula and is responsible 
for severe, sudden visual loss (Holloway and Verhoeff 1929; 
Verhoeff and Grossman 1937). Atrophic AMD, also known 
as geographic atrophy (GA) is characterized by a progressing 
course leading to degeneration of RPE and photoreceptors. 
Studies have shown that the atrophy initially tends to develop 
in the perifoveal area, while the fovea may be spared until 
later during the clinical course (Sarks et al 1988; Sunness 
1999). GA is characterized by a loss of the outer neurosen-
sory retina, the RPE, and the choriocapillaris (Figure 4). 
The primary dysfunction and cell death of the RPE cells 
is thought to occur initially, followed by collateral loss of 
neighboring photoreceptor cells and choriocapillaris (Sarks 
et al 1988; Roth et al 2004). Previous studies have shown 
that photoreceptor apoptosis is involved in AMD pathology 
(Green and Enger 1993; Xu et al 1996). Recently, another 
study quantiﬁ  ed the number of TUNEL-positive cells in each 
retinal layer in cryosections of AMD and control eyes. The 
authors showed that maculas with AMD had a statistically 
signiﬁ  cant increase in TUNEL-positive RPE cells compared 
with the control ones. In the GA eyes, TUNEL-positive rods 
and RPE nuclei were present near the edges of RPE atrophy 
(Dunaief et al 2002). Additional data also suggest that A2E, 
a lipofuscin component, induces apoptosis in RPE cultures 
(Suter et al 2000). Finally, apoptosis was also observed in 
surgically excised choroidal neovascular (CNV) membranes 
from AMD-affected eyes (Hinton et al 1998).
Clinical features common in both types of AMD include 
the presence of drusen and hypo- and hyperpigmentation 
of the RPE. Histological features of RPE in AMD include 
accumulation of lipofuscin, formation of drusen and of basal 
deposits in the BM, and alteration in the BM extracellular 
matrix (Hogan 1972; Sarks 1976; Young 1987; Green and 
Enger 1993; Roth et al 2004; Nowak 2006). As mentioned 
above, these features are also observed, with lower intensity, 
in the aging RPE. However, the changes in AMD lead to 
severe loss of vision.
AMD is a multifactor disease with genetic components 
(Klaver and Allikmets 2003; Gold et al 2006; Hageman et al 
2006; Scholl et al 2007). However, exogenous factors such as 
light exposure, a high fat diet, high blood pressure, and smok-
ing (Leibowitz et al 1980; Cruickshanks et al 1993; Cousins 
et al 2002) are known to modulate its pathogenesis. In addi-
tion, abnormal regulation of the complement system, likely 
caused by the Y402H polymorphism in the complement 
factor H gene on 1q, is a recognized risk factor for AMD, as 
is the A69S variant in the poorly characterized LOC387715 
gene and the serine protease HTRA1 in multiple populations 
(Edwards et al 2005; Haines et al 2005; Jakobsdottir et al 
2005; Klein et al 2005; Rivera et al 2005; Dewan et al 2006; 
Figure 4 RPE cell loss in geographic atrophy. Gross photomicrography of a postmortem eye from an AMD donor with geographic atrophy (GA) (A). Arrows indicate the edges 
of GA; inset indicates the region cut and processed for transmission electron microscopy. Semi-thin epon sections stained with toluidine blue of this region demonstrates 
extensive RPE, photoreceptors and choroids atrophy in the GA region (B) while the edge of GA displays more RPE cells and the presence of some photoreceptor outer seg-
ments (C). In the region outside of the GA the RPE layer is continuous and the photoreceptors’ inner and outer segments can be observed (D). Arrowheads point to Bruch’s 
membrane. Debris accumulation is observed underneath the RPE cells in all regions observed. Bars 200 μm.Clinical Ophthalmology 2008:2(2) 421
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Yang et al 2006). On the other hand, polymorphisms in the 
factor B and complement component 2 are associated with 
decreased susceptibility to AMD (Gold et al 2006; Spencer 
et al 2007). Previous studies had identiﬁ  ed the genes ABC4, 
APOE, TLR4, and FBLN5 as being associated with suscep-
tibility to AMD. However, the fraction of AMD patients 
carrying sequence changes in these genes was very small 
(Scholl et al 2007).
As mentioned above, complement activation has been 
implicated in susceptibility to AMD, mainly through 
complement factor H. It is synthesized mainly in the liver 
and released into the blood where it is transported to other 
tissues. However, high levels of complement factor H are 
detected in the retina-choroid interface (Mandal and Ayyagari 
2006; Chen et al 2007). This expression increases with age 
(Mandal and Ayyagari 2006). In addition, it was suggested 
that the RPE synthesizes complement factor H locally 
(Hageman et al 2005). The RPE production of factor H would 
increase the local concentration of complement regulators 
and provide protection to inappropriate complement activa-
tion at sites of infection and inﬂ  ammation (Rodriguez et al 
2004). This mechanism would be particularly important in 
the retina, as the complement factors supplied by the blood 
may be restricted through the blood-brain barrier (Mandal 
and Ayyagari 2006).
Several reports have shown that oxidative mechanisms 
constitute the initial stimulus that triggers apoptosis, thereby 
contributing to the progression of AMD. The retina is highly 
susceptible to photo-oxidative damage due to its high oxygen 
demand, life-long exposure to light and the presence of poly-
unsaturated fatty acids highly enriched in the photoreceptor 
outer segments (Beatty et al 2000; Roth et al 2004). This 
scenario is aggravated with age, for there is a reduction in 
the local antioxidative enzymes in the RPE and a decrease in 
macular pigment density, which serves not only as a ﬁ  lter for 
short-wavelength light, but also as an antioxidant, through 
its two constituents, lutein and zeaxanthin. The age-related 
increase in oxidative stress leads to cellular events which 
in turn induce the histopathological changes associated 
with AMD, as described above. An animal model recently 
described the connection between oxidation, inﬂ  ammation 
and pathology of AMD. In this model, mice were injected 
with mouse serum albumin adducted with carboxyethylpyr-
role, an oxidation fragment generated from the protoreceptor-
enriched lipid docosahexaenoic acid. Injected mice develop 
antibodies to this hapten, ﬁ  x high amounts of complement 
component 3 in Bruch’s membrane, accumulate drusen below 
the RPE, and develop lesions in the RPE-photoreceptor 
interface that mimic AMD (Hollyﬁ  eld et al 2007). The 
severity of the cellular lesions correlated with the antibody 
production titer.
Outlook
The aged RPE is characterized by several structural changes, 
which are exacerbated in AMD. These structural changes are 
known to be associated with an increase in oxidative stress 
and general decline of basic functions. Recently, it became 
evident that RPE and choriocapillaris express many if not 
all of the components and regulators of the complement 
cascade. Moreover, the RPE also plays an important role in 
the development of immune and inﬂ  ammatory responses in 
the posterior part of the eye through production of cytokines. 
However, little is known about it in aging. The connection 
between oxidation and immune system in aging will provide 
a powerful approach for the elucidation of the many senile 
degenerative macular and peripheral retinal diseases such 
as AMD.
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